cognitive cybersecurity intelligence

News and Analysis

Search

NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury

Evaluators concluded that UroShield has the potential to improve quality of life and reduce healthcare associated costsELMSFORD, N.Y., March 14, 2023–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company utilizing the Company’s proprietary and patented…

Source: finance.yahoo.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts